Mirum Pharmaceuticals, Inc. MIRM Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s other working capital?
- Mirum Pharmaceuticals, Inc. (MIRM) reported other working capital of $278K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s other working capital changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s other working capital decreased by 21.9% year-over-year, from $356K to $278K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s other working capital?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s other working capital has grown at a -26.4% compound annual growth rate (CAGR), from $3.51M to $1.4M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.